Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius    FRE   DE0005785604

FRESENIUS

(FRE)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
  • The company is in debt and has limited leeway for investment
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
  • The technical configuration over the long term remains negative on the weekly chart below the resistance level at 52.82 EUR
Ratings chart
Sector Hospitals, Clinics & Primary Care Services
1st jan.Capitalisation (M$)Investor Rating
FRESENIUS8.85%28 748
AIER EYE HOSPITAL GROUP CO ..--.--%12 927
BANGKOK DUSIT MEDICAL SERVI..--.--%12 741
IHH HEALTHCARE BHD--.--%11 573
RAMSAY HEALTH CARE LIMITED24.15%9 884
HAPVIDA PARTICIPACOES E INV..21.22%6 362
NOTRE DAME INTERMEDICA PART..40.65%5 581
PREMIER INC-0.88%4 719
TOPCHOICE MEDICAL CORPORATI..69.29%3 746
HEALTHSCOPE LTD10.31%3 003
MEDICLINIC INTERNATIONAL-7.04%2 907
THE ENSIGN GROUP, INC.45.94%2 810
APOLLO HOSPITALS ENTERPRISE..8.92%2 729
AL MOUWASAT MEDICAL SERVICE..--.--%2 272
AMN HEALTHCARE SERVICES, IN..-8.97%2 263
MITRA KELUARGA KARYASEHAT T..--.--%1 874
More Results
Financials (€)
Sales 2019 35 249 M
EBIT 2019 4 681 M
Net income 2019 1 884 M
Debt 2019 17 362 M
Yield 2019 1,77%
P/E ratio 2019 13,82
P/E ratio 2020 12,77
EV / Sales 2019 1,22x
EV / Sales 2020 1,12x
Capitalization 25 543 M
Upcoming event on FRESENIUS
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes